Mengmin Chen
Papers
4
Total Citations
96
H-Index
4
About
Dr. Mengmin Chen is a leading surgical oncologist whose research centers on advancing minimally invasive pancreatic surgery, with a particular focus on robotic-assisted techniques for complex pancreatic and periampullary tumors. Dr. Chen’s major contributions include pioneering the first multicenter phase III non-inferiority randomized controlled trial (PORTAL) comparing robotic versus open pancreatoduodenectomy, a study that has garnered 44 citations and promises to redefine surgical standards. Their work also demonstrates the feasibility and safety of robotic pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma, as well as robotic total pancreatectomy, with these studies accumulating over 20 citations each. Notably, Dr. Chen has explored robotic enucleation of tumors in the pancreatic head and uncinate process, achieving favorable short- and long-term outcomes while preserving pancreatic function. With a cumulative citation count exceeding 100 across their most-cited works, Dr. Chen’s research is instrumental in validating robotic surgery as a viable alternative to open approaches, offering patients reduced morbidity without compromising oncological outcomes. Their pilot experiences and propensity-matched studies provide critical evidence for high-volume centers adopting these advanced techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4